Elisabeth Mahase

Publications775
h-index34
Citations6,371
Highly Influential Citations218
Claim Author Page
Author pages are created from data sourced from our academic publisher partnerships and public sources.

Recommended Authors

  • G. Iacobucci
  • 1,499 Publications • 3,770 Citations
  • O. Dyer
  • 1,104 Publications • 3,281 Citations
  • J. Wise
  • 1,635 Publications • 4,234 Citations
  • A. Rimmer
  • 1,592 Publications • 1,680 Citations
  • Publications
  • Influence
Coronavirus: covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate
The novel coronavirus that has so far spread from China to 26 countries around the world does not seem to be as “deadly as other coronaviruses including SARS and MERS,” the World Health Organization…
View on Publisher
Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction
Covid-19 has officially been declared a pandemic by the World Health Organization, as its director general, Tedros Adhanom Ghebreyesus, warned that he was “deeply concerned both by the alarming…
View on BMJ
China coronavirus: WHO declares international emergency as death toll exceeds 200
The World Health Organization has declared the current novel coronavirus (2019-nCoV) outbreak to be a public health emergency of international concern, as latest figures show that nearly 10 000…
View on Publisher
Covid-19: Where are we on vaccines and variants?
Nearly a year after WHO declared the covid-19 pandemic, Elisabeth Mahase reports on the latest developments in vaccines, variants, and diplomacy
View on Publisher
Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
TLDR
In the study, trial participants were randomised 1:1, with half receiving paxlovid and the other half receiving a placebo orally every 12 hours for five days, with statistical significance of these results reported as high.
View on BMJ
Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows
The UK government has secured five million doses of the covid-19 vaccine candidate mRNA-1273 from US biotech company Moderna after interim analysis of its phase III trial showed it was 94.5%…
View on Publisher
Covid-19: What do we know about “long covid”?
As recognition grows that many patients have long lasting effects, Elisabeth Mahase examines the evidence and the response
View on Publisher
Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
TLDR
The trial tested two doses of the vaccine administered threeweeks apart and reported 62 symptomatic cases of covid-19, of which 56 were in the placebo group (saline) and six in the vaccine group.
View on Publisher
Covid-19: Doctors are told not to perform CPR on patients in cardiac arrest
Healthcare staff in the West Midlands have been told not to start chest compressions or ventilation in patients who are in cardiac arrest if they have suspected or diagnosed covid-19 unless they are…
View on BMJ
Covid-19: What new variants are emerging and how are they being investigated?
The new, more transmissible variant of SARS-CoV-2 found in England is just one of many variations of the virus being detected around the world. Elisabeth Mahase looks at what we know so far
View on Publisher
...
...